FutureWorld (FWDG) subsidiary URVape Announces the Launch of its CBD E-liquids

URVape Launches SafeVapeTM CBD Based Products

St. Petersburg, Florida, UNITED STATES

ST. PETERSBURG, FL, Feb. 26, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTC; FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces today that its subsidiary, URVape, Inc., has launched two CBD E-liquid products for Vaping. Both products are natural formulations of CBD from Hemp, Non-GMO Vegetable Glycerin, Sunflower, and Stevia. CBD ORIGINALTM consists of an unadulterated blend of laboratory tested CBD. CBD ENHANCEDTM consists of the same CBD content as CBD ORIGINALTM with the addition of two natural herbal extracts shown to be effective for lung healing and expectoration.

"The launch of our CBD line of E-liquids follows months of laboratory research and development to bring to market our SafeVapeTM product line of Vaping devices and e-liquids", commented CEO of URVape, Dan Montgomery. "CBD is one of nature's bodyguards, and has been shown to have a positive effect on many human conditions such as: arthritis; Type-2 diabetes; inflammation; anxiety; ADHD and others, many of which are in clinical trials" added Mr. Montgomery

Urvape Inc., under Mr. Montgomery's direction, is developing a new standard of vaping that will be meet consumer demand for a satisfying vaping experience coupled with products that prohibit any harmful substances from entry into the lungs while vaping.  SafeVape™ has been trademarked and will become the quintessential seal that will mark a new era of safe vaping devices and e-liquids.  Much that is on the market today does not factor into the equation of the proper heating calibration and safety of the device with the solution being vaped.  Consequently, many harmful products are being inhaled.  Urvape, pledges to rectify the status quo starting with its own new products.

Retail purchases may be made on the URVape website www.urvape.com. Wholesalers and vape shops may order by setting up an account on the URVape website and then calling URVape sales at (727) 474-2047, or by sending an email to wholesale@urvape.com.

About URVape

URVape (http://www.urvape.com) is a Florida Corporation, wholly owned by FutureWorld Corp., based in Saint Petersburg, Florida. URVape manufactures, markets, and distributes electronic cigarettes, vaporizers, and accessories under the URVape brand name in the United States. It offers vaporizers and related products through its online store urvape.com, as well as through the company's wholesale, distributor, and retail programs. Operating on the idea of open source technology and innovation, the URVape vision is to bring standardized versatility to our customers by offering easily customizable vape pen solutions. URVape supplies avid vape enthusiasts and smokers with a sleek and sophisticated vaporizer that is both affordable and covetable. The Company already plans on adding a loose-leaf herb vape pen, wax vape pen and CBD oil to the mix of offering. The Company is setting the stage for a leading position within the world's 200 billion dollar tobacco market and the multibillion dollar cannabis industry.

After studying the marketplace, with more than 466 vendors attempting to reach consumers, URVape recognized that there were unsupported claims and deficiencies in the products and e-liquids being sold. As a result, URVape has dedicated itself to providing devices that will produce an optimum vaping experience for EBBU and other E-liquids

URVape's has installed its own FDA level "clean-room" for product research, manufacture and production, and plans include expansion into its own medical compliant laboratory for development  of its products with the goal of becoming the market leader of safe products. To that end, URVape has Trademarked "SafeVape" for use in describing the technologies utilized in bring both hardware and e-liquids to the marketplace.

About FutureWorld Corp

FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. FutureWorld, through its subsidiaries such as HempTech and CB Scientific, provides personal and professional THC and CBD test kits, pure CBD oil solutions, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.

To request further information about FutureWorld, please email us at investors@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page https://www.facebook.com/futureworldenergy or on Twitter #futureworldinc.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.